SCHEMBL6004629

SCHEMBL6004629

O=C(c1ccc(OCCC2CCCCCN2)cc1)c1c(-c2ccccc2F)ccc2cc(O)ccc12

nearest known ligand 0.44

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CHEK2 O96017 1/20 0.44
ESR1 P03372 18/20 0.42
ESR2 Q92731 17/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6003305 0.99 CHEK2 (0.43) CHEK2ESR1ESR2
SCHEMBL6004620 0.93 CHEK2 (0.44) CHEK2ESR1ESR2
SCHEMBL6005357 0.93 CHEK2 (0.43) CHEK2ESR1ESR2
SCHEMBL6003362 0.92 CHEK2 (0.43) CHEK2ESR1ESR2
SCHEMBL6004626 0.92 CHEK2 (0.44) CHEK2ESR1ESR2
SCHEMBL6005869 0.92 CHEK2 (0.44) CHEK2ESR1ESR2
Hydrochloric Acid SCHEMBL6003391 0.91 CHEK2 (0.43) CHEK2ESR1ESR2
SCHEMBL6003282 0.91 CHEK2 (0.43) CHEK2ESR1ESR2
SCHEMBL6004724 0.91 CHEK2 (0.43) CHEK2ESR1ESR2
SCHEMBL6005679 0.91 CHEK2 (0.44) CHEK2ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1709021-A1 SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ELI LILLY AND COMPANY (US) 2006-10-11 EP disclosed
WO-2005073204-A1 SELECTIVE ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF VASOMOTOR SYMPTOMS ELI LILLY AND COMPANY (US) 2005-08-11 WO disclosed